THC Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of THC Therapeutics generated cash of -$85,432, which is more than the previous year. Cash used in financing activities reached the amount of $85,410 last year. Net change in cash is therefore -$22.
Cash Flow
| 2014 | -91.78K | 0 | 82.47K |
|---|---|---|---|
| 2015 | -11.91K | 0 | 12.5K |
| 2016 | -17.31K | 0 | 11.14K |
| 2017 | -156.73K | -20K | 176.67K |
| 2018 | -190.16K | -532 | 193.47K |
| 2019 | -329.80K | -1.19K | 645.58K |
| 2020 | -587.93K | 0 | 313.62K |
| 2021 | -388.47K | -152.78K | 794.15K |
| 2022 | -418.91K | 0 | 122.81K |
| 2023 | -85.43K | 0 | 85.41K |
THCT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 32 | 296.13K | 43.23K | 317.55K | 2.96K | 187 | 245 | 6.46K | 5.88K | 15.2K |
Operating activities | ||||||||||
Net income | -387.03K | -1.51M | -1.88M | -1.92M | -23.30M | -6.13M | -15.59M | -91.99K | -284.29K | -576.04K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.39K | 12.33K | 16.37K | 20.11K | 25.55K | 25.43K | 152.86K | 0 | 0 | 0 |
Stock-based compensation expense | 87.17K | 836.78K | 115.69K | 438.43K | 23.82M | 0 | 97.42K | 0 | 195.35K | 340.47K |
| Deferred income tax benefit | 87.17K | 836.78K | 115.69K | 438.43K | 23.82M | 0 | 97.42K | 0 | 195.35K | 340.47K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 25 | 805 | -830 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 358.93K | 598.97K | 418.79K | 217.33K | 226.85K | 106.10K | 23.65K | 0 | 0 | 0 |
Cash generated by operating activities | -85.43K | -418.91K | -388.47K | -587.93K | -329.80K | -190.16K | -156.73K | -17.31K | -11.91K | -91.78K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -152.78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 2 | 0 | 0 | 0 | -1.19K | -532 | -20K | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -152.78K | 0 | -1.19K | -532 | -20K | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 100K | 147K | 506.5K | 0 | 0 | 65K | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -97.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 25K | -103.42K | -266.41K | 645.58K | -116.18K | 0 | 0 | 12.5K | 0 |
Cash used in financing activities | 85.41K | 122.81K | 794.15K | 313.62K | 645.58K | 193.47K | 176.67K | 11.14K | 12.5K | 82.47K |
Net Change In Cash | -22 | -296.09K | 252.89K | -274.31K | 314.58K | 2.78K | -58 | -6.17K | 581 | -9.31K |
Cash at end of period | 10 | 32 | 296.13K | 43.23K | 317.55K | 2.96K | 187 | 296 | 6.46K | 5.88K |
| Data source | Data source | Data source | Data source | Data source |